Schmieder A, Jacobs H
Strahlentherapie. 1985 May;161(5):270-4.
A retrospective study of primary irradiated carcinomas of the uterine cervix was made in order to compare the effect of radium with the effect of a 192Ir afterloading therapy with high dose rate which had been introduced 2 1/2 years before. A group of 31 patients treated with iridium was opposed to a historical control group of 24 patients treated with radium. Both groups were submitted to the same method of simultaneous percutaneous irradiation. All consecutively treated patients exposed to a percutaneous focal dose of greater than 45 Gy were evaluated. The iridium and radium doses applied as well as the values measured in intestine and bladder are presented. The iridium group had the same or a slightly less favorable prognosis (prognostic factors compared: stage, percutaneous dose, histology, age) than the radium group. The remission rates were identical for both therapy methods. Patients treated with iridium have a slightly better curve of recurrence-free interval and survival time, even taking into consideration the shorter observation period. Two out of the patients treated with iridium and four out of those treated with radium presented severe long-term side effects with formation of fistulas (average incidence 12,5 months and 12,7 months after the beginning of therapy, respectively).
为了比较镭与两年半前引入的高剂量率铱后装治疗对子宫颈原发性照射癌的疗效,进行了一项回顾性研究。一组31例接受铱治疗的患者与一个24例接受镭治疗的历史对照组相对照。两组均采用相同的同步经皮照射方法。对所有连续接受经皮局部剂量大于45 Gy治疗的患者进行了评估。列出了应用的铱和镭剂量以及在肠道和膀胱中测量的值。铱组的预后(比较的预后因素:分期、经皮剂量、组织学、年龄)与镭组相同或略差。两种治疗方法的缓解率相同。即使考虑到观察期较短,接受铱治疗的患者无复发生存期和生存时间曲线也略好一些。接受铱治疗的患者中有2例,接受镭治疗的患者中有4例出现了形成瘘管的严重长期副作用(分别在治疗开始后平均12.5个月和12.7个月出现)。